Bussiness5 months ago
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
It was a far cry from the year prior, when Pfizer’s shares plunged more than 40%, making it one of the worst-performing large pharmaceutical stocks of...
